Clinical Trial Update: Probiotic Use for Recovery Enhancement From Long COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating probiotic therapy to aid recovery from Post-Acute COVID-19 Syndrome (Long COVID); the study is sponsored by Rush Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute COVID-19 Syndrome

Drugs mentioned

• Probiotic therapy (unspecified)

Snippet

Sponsor: Rush University Medical Center | Conditions: Post-Acute COVID-19 Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING